Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

SuperGen clarifies interim data from phase III study of Dacogen in MDS

March 12, 2004

Iressa approved in Switzerland

March 12, 2004

Phase II trial studies PT-100 combination therapy for advanced NSCLC

March 12, 2004

Novel poly(ADP-ribose) polymerase-1 inhibitor restores sensitivity to temozolomide

March 12, 2004

Pfizer researchers report new inhibitors of TRK and other kinases for cancer therapy

March 12, 2004

Schering-Plough and Pharmacopeia report new CXCR ligands and their use

March 12, 2004

Phenoxodiol evaluated in combination therapy for late-stage renal carcinoma

March 12, 2004

New phase I/IIa study to evaluate Telcyta combination therapy for NSCLC

March 11, 2004

Nippon Shinyaku scientists discover Bcr-Abl kinase inhibitors for use in leukemia therapy

March 11, 2004

Pfizer describes inhibitors of CDKs and tyrosine kinases and their therapeutic use

March 11, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...